BioMarin Pharmaceutical, Inc. (BMRN)
54.59
-0.48
(-0.87%)
USD |
NASDAQ |
Jan 16, 16:00
54.62
+0.03
(+0.05%)
After-Hours: 20:00
BioMarin Pharmaceutical Profit Margin (Quarterly): -3.91% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 10.24% |
| Gilead Sciences, Inc. | 39.21% |
| Merck & Co., Inc. | 33.68% |
| AbbVie, Inc. | 1.13% |
| Biogen, Inc. | 19.00% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.99% |
| Return on Assets | 7.22% |
| Return on Invested Capital | 8.12% |
| Gross Profit Margin (Quarterly) | 81.58% |
| Operating Margin (Quarterly) | 23.50% |
| Return on Net Operating Assets | 14.66% |